Cargando…
Effect of Co-Treatment of Olanzapine with SEP-363856 in Mice Models of Schizophrenia
Olanzapine is a commonly used drug in the treatment of schizophrenia, but its clinical application has been restricted by metabolic-related side effects. In order to mitigate the weight gain side effects caused by olanzapine, other drugs with different targets were selected for combined use and eval...
| Autores principales: | , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9024832/ https://www.ncbi.nlm.nih.gov/pubmed/35458749 http://dx.doi.org/10.3390/molecules27082550 |